A new method for assessing the effectiveness of experimental diabetic models for assessing blood rheology
N.Sakhanberidze

, M.Namoradze

, N.Charkviani

, N.Momtselidze

, G.Kuchava

, N.Antonova

, M.Mantskava

Abstract: Objective. Diabetes is a complex system of diseases associated with violating all types of metabolism: carbohydrate, fat, protein, mineral and water-salt. Diabetes requires special attention from the fundamental scientific and clinical medicine sides. Of course, rheology is one of the factors that change in diabetes and rheological studies in diabetes are of relevance for the success and timely treatment of manifestations and complications of diabetes. Materials and Methods. Experimental models of diabetes are widely used in modern biomechanics to determine several factors in the course and treatment of the disease. To investigate effectiveness of different experimental models, we introduced the parameter effective coefficient of models for rheological research and conducted laboratory rheological studies on various types of models (surgical, dithizone, alloxan, streptozotocin). Results. Considering all the factors, it turned out that the streptozotocin model is most suitable for rheological studies. Discussion. Existing useful models of diabetes have not yet been assessed in terms of the suitability of rheological studies. Some models of diabetes may have established themselves as easily and comfortably used, but for rheological research they are not effective. The coefficient we have introduced describes the effectiveness of the model for studying the rheology in diabetes. Conclusion. Considering all the factors, we have concluded that the streptozotocin model is the most suitable for rheological studies.
Series on Biomechanics, Vol.39, No.1 (2025),17-23
DOI:10.7546/SB.01.03.2025
Keywords: aggregation; deformation; RBC; Rheological properties
References: (click to open/close) | [1] Lv, K., Cui, C., Fan, R., Zha, X., Wang, P., Zhang, J., Zhang, L., Ke, J., Zhao, D., Cui, Q., Yang, L. 2023. Detection of diabetic patients in people with normal fasting glucose using machine learning. BMC Med. 7, 21, 1, 342. doi: 10.1186/s12916-023-03045-9. PMID: 37674168; PMCID: PMC10483877. [2] Harreiter, J., Roden, M. 2023. Diabetes mellitus - Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023) [Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023)]. Wien Klin Wochenschr. 135, 1, 7-17. German. doi: 10.1007/s00508-022-02122-y. Epub 2023 Apr 20. PMID: 37101021; PMCID: PMC10133036. [3] Mantskava, M., Chkhitauri, L., Shekiladze, E., Tskhvediani, N., Kalmakhelidze, S., Momtselidze, N., Prantl, L., Jung, F., Machaliński, B., Wojciech, P., Sanikidze, T. 2024. Impact of different severity hyperglycemia on erythrocyte rheological properties1. Clin Hemorheol Microcirc. 87, 2, 271-281. doi: 10.3233/CH-239104. PMID: 38363605. [4] Chkhitauri, L., Sanikidze, T., Giorgadze, E., Asatiani, K., Kipiani, N., Momtselidze, N., Mantskava, M. 2023. Comprehensive study of the rheological status and intensity of oxidative stress during the progression of type 2 diabetes mellitus to prevent its complications. Clin Hemorheol Microcirc. 83, 1, 69-79. doi: 10.3233/CH-221512 [5] Pargalava, N., Mantskava, M., Mchedlishvili, G. 2004. Regional and systemic hemorheological disorders during feet diabetic gangrene. Clin Hemorheol Microcirc. 30, 3-4, 457-9. PMID: 15258386. [6] Mantskava, M., Momtselidze, N., Pargalava, N., Mchedlishvili, G. 2006. Hemorheological disorders in patients with type 1 or 2 diabetes mellitus and foot gangrene. Clin Hemorheol Microcirc. 35, 1-2, 307-10. PMID: 16899949. [7] Momtselidze, N., Mantskava, M., Mchedlishvili, G. 2006. Hemorheological disorders during ischemic brain infarcts in patients with and without diabetes mellitus. Clin Hemorheol Microcirc. 35, 1-2, 261-4. PMID: 16899939. [8] Mantskava, M., Pargalava, N., Mchedlishvili G. 2004. Direct beneficial effect of insulin on blood rheological disorders in the microcirculation. Clin Hemorheol Microcirc. 30, 3-4, 431-3. PMID: 15258380. [9] Furman, BL. 2021. Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr Protoc. 1, 4, e78. doi: 10.1002/cpz1.78. PMID: 33905609. [10] Abid, S., Bnouham, M. 2023. A Review on Experimental Models to Test Medicinal Plants on Postprandial Blood Glucose in Diabetes. Curr Diabetes Rev. 19,9: e080422203278. doi: 10.2174/1573399818666220408100830. [11] Mchedlishvili, G. 2007. Hemorheological changes in microcirculation: Their mechanism and measurement technique. Indian Journal of Experimental Biology 45, 1, 32-40 [12] European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. https://rm.coe.int/168007a67b [13] Okamoto, K. 1955. Experimental Pathology of Diabetes Mellitus. Tohoku J Exp Med. May 6; 61 (SUPPL. III): 1-116. PMID: 13247319.] [14] Lenz, C., Rebel, A., Waschke, KF., Koehler, RC., Frietsch T. 2008. Blood Viscosity Modulates Tissue Perfusion: Sometimes and Somewhere. Transfus altern Transfus med. 9, 4, 265-272. doi: 10.1111/J.1778-428x.2007.00080.x. PMID: 19122878; PMCID: PMC2519874. [15] Pastacı özsobacı, N., Karış, D., Ercan am, özelik, D. 2024. Investigation of Zinc on Hemorheological Parameters in a Rat Model of Diabetes. J Trace Elem Med Biol. 84, 127450. DOI: 10.1016/J.JTEmb.2024.127450. EPUB 2024 APR 10. PMID: 38643593. [16] Dhuria, RS., Singh, G., Kaur, A., Kaur, R., Kaur, T. 2015. Current status and patent prospective of animal models in diabetic research. Adv Biomed Res. 4, 117. doi: 10.4103/2277-9175.157847. PMID: 26261819; PMCID: PMC4513317. [17] Melnikova, G.B., Kuzhel, N.S., Tolstaya, T.N., Konstantinova, E.E., Drozd, E.S., Shishko, O. N., Mokhort T.G., Antonova, N., Kowalczuk, A., Koseva, N. 2015. Influence of polyacrylic acid nanoparticles on the elastic properties of RBCs membranes in patients with diabetes mellitus type 2. Series on Biomechanics 29, 4, 12-19 [18] Paskova, V., Antonova, N., Chaushev, N., Velcheva, I. 2015. Rheological properties of the blood and changes of oscillations in skin temperature after cold test in patients with type 2 diabetes mellitus Series on Biomechanics 29, 4, 55-59 [19] Alexandrova, A., Antonova, N., Skorkina, M.Yu., Shamray, E., O. Cherkashina, V. 2017. Evaluation of the elastic properties and topography of leukocytes surface in patients with type 2 diabetes mellitus using atomic force microscope. Series on Biomechanics 31, 3, 16-24 [20] Paskova, V., Antonova, N., Ivanov, I., Velcheva, I., Chaushev, N. 2019. Rheological and electrical behaviour of blood in patients with diabetes mellitus type 2. Series on Biomechanics 33, 1, 51-58 [21] Viswanathaswamy, A.H. et. al. 2011. Antihyperglycemic and antihyperlipidemic activity of plectranthus amboinicus on normal and alloxaninduced diabetic rats. Ind. J. Pharm. Sci. 73, 139-45 [22] Lenzen, S. 2008. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 51, 2, 216-26. doi: 10.1007/s00125-007-0886-7. Epub 2007 Dec 18. PMID: 18087688.]. [23] Radenković, M., Stojanović, M., Prostran, M. 2016. Experimental diabetes induced by alloxan and streptozotocin: The current state of the art. J Pharmacol Toxicol Methods. 78, 13-31. doi: 10.1016/j.vascn.2015.11.004. Epub 2015 Nov 17. PMID: 26596652.]. [24] Rahman, MO., Alqahtani, AS., Huda, SB., Siddiqui, SA., Noman, OM., Nasr, F., Hassan, MA., Islam, SN. 2021. Streblus asper attenuates alloxan-induced diabetes in rats and demonstrates antioxidant and cytotoxic effects. Pharm Biol. 59, 1, 1058-1064. doi: 10.1080/13880209.2021.1954668. [25] Thorens, B., Sarkar, HK., Kaback, HR., Lodish, HF. 1988. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell 55, 2,281-90. doi: 10.1016/0092-8674(88)90051-7. PMID: 3048704. [26] Karran, P., Bignami., M. 1992. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res. 20(12):2933-40. doi: 10.1093/nar/20.12.2933. PMID: 1620587; PMCID: PMC312419 [27] Murata, M., Takahashi, A., Saito, I., Kawanishi, S. 1999. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem Pharmacol. 57, 8, 881-7. doi: 10.1016/s0006-2952(98)00370-0. PMID: 10086321
|
|
| Date published: 2025-03-25
(Price of one pdf file: 39.00 BGN/20.00 EUR)